These findings are potentially important since such bacteria could provide H. pylori with the chance to acquire drug resistance and to transfer drug resistance genes. This could be one reason why H. pylori is difficult to eradicate in the remnant stomach.
Helicobacter pylori is a Gram-negative curved rod-like or spiral bacterium that chronically infects the gastric mucosa in humans1). It is a major risk factor for gastritis, gastric or duodenal ulcer2-4) and adenocarcinoma of the stomach5,6). Following partial gastrectomy, it has been reported that the rate of H. pylori infection decreases over time, but some patients still have H. pylori infection after five years or more7,8). In this study, we investigated the bacteria in the gastric juice of patients with a remnant stomach to determine whether any of these bacteria
Materials and Methods

Bacterial Strains and Plasmids
The Eschericha coli KU2273 derived from K-12 strain and bearing plasmid RP4 as well as American Type Culture Collection (ATCC) H. pylori 43629 were used. Several E. coli (KU6269 and KU6270), Enterobacter aerogenes (KU6271, KU6272, and KU6273) and Klebsiella pneumoniae (KU6274, KU6275, and KU6276) strains were clinical isolates from the gastric juice of patients with a remnant stomach who were admitted to the Gastroenterology ward of Kitasato University Hospital in 1999.
Culture Medium
Test strains for the sensitivity assays were incubated in Mueller Hinton broth and agar (MH, Nissui, Tokyo, Japan). L-broth containing 5g of peptone tryptone (Difco Laboratories, MI, USA), 2.5g of yeast extract (Difco Laboratories) and 2.5g of sodium chloride (Wako, Pure Chemical, Industries, Tokyo, Japan) was used for the assay H. pylori was grown for 4 days on trypto-soy agar (TSA;
Eiken Chemical, Tokyo, Japan) supplemented with 5% 10.5% CO2.
Test Drugs
Several antibacterial agents were tested in this study. The respective manufacturers kindly provided reference powders for the following drugs of known potency: ampicillin (AMP, Meiji Seika Kaisha, Tokyo, Japan), piperacillin (PIPC, Toyama Chemical, Tokyo, Japan), cephalothin (CET, Shionogi Seiyaku, Osaka, Japan), ceftazidime (CAZ, Glaxo SmithKline, Tokyo, Japan), imipenem (IPM, Banyu Seiyaku, Tokyo, Japan) and nalidixic acid (NA, Sigma, Tokyo, Japan).
Determination of MICs
Drug resistance was assessed by determining the minimum inhibitory concentration (MIC) that inhibited the visible growth of bacteria using the agar dilution method. After that, an equal volume (0.5ml) of each bacterial the mixed culture fluid was spread onto agar containing incubated for 3 days, after which it was checked for growth of H. pylori.
Results and Discussion
We isolated one or more species of bacteria from the gastric juice obtained from 6 of 18 patients with a remnant stomach. These bacteria were K. pneumoniae, E. aerogenes, and E. coli (Table 1 ). In this study, we did not investigate the presence of H. pylori in any of these patients. Other acquire drug resistance via the transfer of drug-resistance genes in plasmids, transposons, and chromosomal elements of these organisms. It is important to monitor drug sensitivity of H. pylori.
